An amylin analog used as a challenge test for Alzheimer's disease

INTRODUCTION: Preclinical studies demonstrate the potential of amylin in the diagnosis of Alzheimer's disease (AD). We aimed to lay the foundation for repurposing the amylin analog and a diabetes drug, pramlintide, for AD in humans. METHODS: We administered a single subcutaneous injection of 60...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Alzheimers Dement (N Y)
Päätekijät: Zhu, Haihao, Stern, Robert A., Tao, Qiushan, Bourlas, Alexandra, Essis, Maritza D., Chivukula, Meenakshi, Rosenzweig, James, Steenkamp, Devin, Xia, Weiming, Mercier, Gustavo A., Tripodis, Yorghos, Farlow, Martin, Kowall, Neil, Qiu, Wei Qiao
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2017
Aiheet:
Featured Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5424531/
https://ncbi.nlm.nih.gov/pubmed/28503657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2016.12.002
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia